Changes in brain functioning, new synthesis methods, and psychotherapy dominate this year’s most-cited psilocybin papers.
This study provides meaningful access to some lesser-known magic mushroom compounds and conducts biological testing on them for the first time.
Interestingly, changes in migraine frequency were not correlated with the intensity of the acute psychotropic effects.
This influential study advances the understanding of magic mushroom physiology and helps answer several fundamental questions.
A recent study shows DMT reduces the cellular stress caused by a stroke and speeds up recovery time in rats. These findings highlight the expanding therapeutic potential of DMT regarding neurological disorders.
Brain imaging research reveals where psychedelic compounds such as psilocybin and LSD manifest their effects.
There is much research into psychedelic treatment of mental disorders, but psychedelics might be effective in treating autoimmune disorders as well.
Psychedelic-assisted psychotherapy leads the way in 2020’s top psychedelic papers.
The monoamine hypothesis of depression leaves many patients without effective help. It’s time for a paradigm shift, and psychedelics may be leading the way.
Escalating LSD doses lead to more pronounced subjective and autonomic effects, while pre-administration of ketanserin prevents the effects of a high LSD dose.